Aberra Internal Medicines Sioux Falls, SD - 57105

Aberra Internal Medicines is categorized under Internal Medicine Practitioners in Sioux Falls, SD and active since 2008.

Aberra Internal Medicines was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Becky Snethen at the company’s single location by writing to 1301 South Cliff Avenue # 400, Sioux Falls, South Dakota SD 57105 or by phoning (605) 322-5753. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Aberra Internal Medicines
Contact Person: Becky Snethen
Address: 1301 South Cliff Avenue # 400, Sioux Falls, South Dakota 57105
Phone Number: (605) 322-5753
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Aberra Internal Medicines was started in 2008 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Becky Snethen for inquiries that concern Aberra Internal Medicines by calling the company number (605) 322-5753, as your correspondence is most welcome. Additionally, the physical location of the single location of Aberra Internal Medicines can be found at the coordinates 43.534702,-96.711509 as well as the street address 1301 South Cliff Avenue # 400 in Sioux Falls, South Dakota 57105.

For its online presence, you may visit Aberra Internal Medicines’s website at and engage with its social media outlets through on Twitter and on Facebook.